Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Sep 1;18(9):2380–2385. doi: 10.1158/1055-9965.EPI-09-0144

Table 3.

Correlation of FAS immunohistochemical expression with serum FAS ELISA

FAS ELISA+* FAS ELISA − Total P
Pancreatic adenocarcinoma 0.44
 FAS IHC strong+ 5 1 6
 FAS IHC weak+/− 8 4 12
IPMN
 FAS IHC strong+ 3 2 5 0.36
 FAS IHC weak+/− 3 0 3

Abbreviation: IHC, immunohistochemistry

*

FAS ELISA is considered positive at a level of >14.7 ng/mL.